Efficacy and safety of pulsed infusions of levosimendan in outpatients with advanced heart failure

Registry ID

EUCTR2008-007407-86

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Medizinische Universität Innsbruck - Universitätsklinik für Innere Medizin III

Start date

2009-09-14

Last update

2026-08-16

Conditions

• Chronic heart failure

Summary

The primary efficacy objective of the study is to compare the effects of a pulsed application of Levosimendan versus placebo of the composite end-point functional capacity and quality of life.

Locations

• , , Greece
• , , Austria
• , , Germany

View on source registry